Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Dec-22 8:09 AM View:  | Henwood Geraldine President and CEO Director | Baudax Bio, Inc. (BXRX) | 15-Dec-22 | Purchase | 1,200 | $2.55 | $3,057.12 | 97% 1.24K to 2.44K | |
| 17-Jun-22 4:13 PM View: | Ashton William Director | Baudax Bio, Inc. (BXRX) | 15-Jun-22 | Grant | 39,473 | -- | -- | 1290% 3.06K to 42.53K | |
| 17-Jun-22 4:12 PM View: | Churchill Winston J Director | Baudax Bio, Inc. (BXRX) | 15-Jun-22 | Grant | 39,473 | -- | -- | 537% 7.35K to 46.82K | |
| 17-Jun-22 4:10 PM View: | Weisman Wayne Director | Baudax Bio, Inc. (BXRX) | 15-Jun-22 | Grant | 39,473 | -- | -- | 1152% 3.43K to 42.9K | |
| 17-Jun-22 4:10 PM View: | Henwood Geraldine President and CEO Director | Baudax Bio, Inc. (BXRX) | 15-Jun-22 | Grant | 39,473 | -- | -- | 387% 10.19K to 49.66K | |
| 17-Jun-22 4:12 PM View: | Drechsler Andrew T Director | Baudax Bio, Inc. (BXRX) | 15-Jun-22 | Grant | 39,473 | -- | -- | 1808% 2.18K to 41.66K | |
| 17-Jun-22 4:13 PM View: | Baskies Arnold M Director | Baudax Bio, Inc. (BXRX) | 15-Jun-22 | Grant | 39,473 | -- | -- | 1599% 2.47K to 41.94K | |
| 17-Jun-22 4:11 PM View: | Dilmore Jillian Corporate Controller/Secretary | Baudax Bio, Inc. (BXRX) | 15-Jun-22 | Grant | 15,467 | -- | -- | 5707% 0.27K to 15.74K | |
| 23-Dec-21 5:45 PM View: | Henwood Geraldine President and CEO Director | Baudax Bio, Inc. (BXRX) | 15-Dec-21 | Payment of Exercise | 18,636 | $0.31 | $5,777.16 | (5%) 375.35K to 356.72K | (14%) |
| 14-Dec-21 6:27 PM View: | Henwood Geraldine President and CEO Director | Baudax Bio, Inc. (BXRX) | 05-Dec-21 | Payment of Exercise | 9,155 | $0.35 | $3,204.25 | (2%) 384.51K to 375.35K | 4% |
| 23-Sep-21 10:00 PM View: | Henwood Geraldine President and CEO Director | Baudax Bio, Inc. (BXRX) | 22-Sep-21 | Market Purchase | 8,200 | $0.59 | $4,797.82 | 2% 376.31K to 384.51K | 3% |
| 31-Aug-21 5:11 PM View: | Churchill Winston J Director | Baudax Bio, Inc. (BXRX) | 31-Aug-21 | Market Purchase | 100,000 | $0.63 | $62,930.00 | 61% 163.69K to 263.69K | (3%) |
| 23-Aug-21 6:42 PM View: | Casten Richard S Chief Financial Officer | Baudax Bio, Inc. (BXRX) | 20-Aug-21 | Market Purchase | 50,000 | $0.51 | $25,500.00 | 33% 150.0K to 200.0K | 0% |
| 08-Jun-21 4:14 PM View: | Churchill Winston J Director | Baudax Bio, Inc. (BXRX) | 07-Jun-21 | Market Purchase | 25,000 | $0.78 | $19,509.00 | 18% 138.69K to 163.69K | (< 1%) |
| 17-May-21 4:35 PM View: | Casten Richard S Chief Financial Officer | Baudax Bio, Inc. (BXRX) | 14-May-21 | Market Purchase | 25,000 | $0.79 | $19,747.50 | 20% 125.0K to 150.0K | 3% |
| 13-May-21 5:32 PM View: | Baskies Arnold M Director | Baudax Bio, Inc. (BXRX) | 11-May-21 | Market Purchase | 10,000 | $0.82 | $8,200.00 | 13% 76.45K to 86.45K | (3%) |
| 10-May-21 4:12 PM View: | Henwood Geraldine President and CEO Director | Baudax Bio, Inc. (BXRX) | 07-May-21 | Market Purchase | 6,000 | $0.83 | $4,992.00 | 2% 370.31K to 376.31K | 6% |
| 08-Apr-21 7:03 PM View: | Altomari Alfred Director | Baudax Bio, Inc. (BXRX) | 07-Apr-21 | Grant | 56,452 | -- | -- | 92% 61.33K to 117.78K | |
| 08-Apr-21 7:12 PM View: | Weisman Wayne Director | Baudax Bio, Inc. (BXRX) | 07-Apr-21 | Grant | 56,452 | -- | -- | 89% 63.53K to 119.98K | |
| 08-Apr-21 7:11 PM View: | Drechsler Andrew T Director | Baudax Bio, Inc. (BXRX) | 07-Apr-21 | Grant | 56,452 | -- | -- | 282% 20.0K to 76.45K | |
| 08-Apr-21 7:21 PM View: | Baskies Arnold M Director | Baudax Bio, Inc. (BXRX) | 07-Apr-21 | Grant | 56,452 | -- | -- | 282% 20.0K to 76.45K | |
| 08-Apr-21 7:04 PM View: | Ashton William Director | Baudax Bio, Inc. (BXRX) | 07-Apr-21 | Grant | 56,452 | -- | -- | 111% 50.73K to 107.19K | |
| 08-Apr-21 7:08 PM View: | Churchill Winston J Director | Baudax Bio, Inc. (BXRX) | 07-Apr-21 | Grant | 56,452 | -- | -- | 69% 82.23K to 138.69K | |
| 16-Mar-21 5:06 PM View: | Casten Richard S Chief Financial Officer | Baudax Bio, Inc. (BXRX) | 15-Mar-21 | Market Purchase | 25,000 | $1.41 | $35,180.00 | 25% 100.0K to 125.0K | (< 1%) |
| 10-Mar-21 8:24 PM View: | Casten Richard S Chief Financial Officer | Baudax Bio, Inc. (BXRX) | 08-Mar-21 | Grant | 100,000 | -- | -- | 100% 0 to 100.0K | |
| 22-Jan-21 6:27 PM View: | Henwood Geraldine President and CEO Director | Baudax Bio, Inc. (BXRX) | 20-Jan-21 | Grant | 65,435 | -- | -- | 21% 304.87K to 370.31K | |
| 20-Jan-21 7:32 PM View: | Lake Ryan David Chief Financial Officer | Baudax Bio, Inc. (BXRX) | 15-Jan-21 | Grant | 25,000 | -- | -- | 35% 70.91K to 95.91K | |
| 20-Jan-21 7:32 PM View: | Lake Ryan David Chief Financial Officer | Baudax Bio, Inc. (BXRX) | 15-Jan-21 | Payment of Exercise | 26,658 | $1.30 | $34,655.40 | (28%) 95.91K to 69.25K | |
| 09-Dec-20 5:45 PM View: | Lake Ryan David Chief Financial Officer | Baudax Bio, Inc. (BXRX) | 05-Dec-20 | Payment of Exercise | 19,909 | $1.14 | $22,696.30 | (22%) 90.82K to 70.91K | |
| 09-Dec-20 5:45 PM View: | Henwood Geraldine President and CEO Director | Baudax Bio, Inc. (BXRX) | 05-Dec-20 | Payment of Exercise | 83,015 | $1.14 | $94,637.10 | (21%) 387.89K to 304.87K | |
| 24-Nov-20 10:00 PM View: | Altomari Alfred Director | Baudax Bio, Inc. (BXRX) | 23-Nov-20 | Purchase | 5,000 | $1.06 | $5,299.50 | 9% 56.33K to 61.33K | |
| 21-Aug-20 4:20 PM View: | Drechsler Andrew T Director | Baudax Bio, Inc. (BXRX) | 20-Aug-20 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 21-Aug-20 4:25 PM View: | Baskies Arnold M Director | Baudax Bio, Inc. (BXRX) | 20-Aug-20 | Grant | 20,000 | -- | -- | 100% 0 to 20.0K | |
| 08-May-20 8:19 PM View: | Ashton William Director | Baudax Bio, Inc. (BXRX) | 06-May-20 | Grant | 22,951 | -- | -- | 83% 27.78K to 50.73K | |
| 08-May-20 8:20 PM View: | Churchill Winston J Director | Baudax Bio, Inc. (BXRX) | 06-May-20 | Grant | 22,951 | -- | -- | 39% 59.28K to 82.23K | |
| 08-May-20 8:18 PM View: | Altomari Alfred Director | Baudax Bio, Inc. (BXRX) | 06-May-20 | Grant | 22,951 | -- | -- | 69% 33.38K to 56.33K | |
| 08-May-20 8:21 PM View: | Weisman Wayne Director | Baudax Bio, Inc. (BXRX) | 06-May-20 | Grant | 22,951 | -- | -- | 57% 40.58K to 63.53K | |
| 27-Mar-20 3:51 PM View: | Altomari Alfred Director | Baudax Bio, Inc. (BXRX) | 26-Mar-20 | Purchase | 5,000 | $2.34 | $11,700.00 | 18% 28.38K to 33.38K | |
| 30-Mar-20 8:00 PM View: | Churchill Winston J Director | Baudax Bio, Inc. (BXRX) | 26-Mar-20 | Purchase | 25,000 | $2.44 | $61,000.00 | 90% 27.78K to 52.78K | |
| 27-Mar-20 3:53 PM View: | Weisman Wayne Director | Baudax Bio, Inc. (BXRX) | 26-Mar-20 | Purchase | 10,000 | $2.29 | $22,900.00 | 33% 30.58K to 40.58K | |
| 30-Mar-20 8:00 PM View: | Churchill Winston J Director | Baudax Bio, Inc. (BXRX) | 26-Mar-20 | Purchase | 6,500 | $2.28 | $14,820.00 | 12% 52.78K to 59.28K | |
| 29-Jan-20 7:44 PM View: | Henwood Geraldine President and CEO Director | Baudax Bio, Inc. (BXRX) | 27-Jan-20 | Option Exercise | 19,070 | -- | -- | 5% 373.87K to 392.94K | |
| 29-Jan-20 7:45 PM View: | Lake Ryan David Chief Financial Officer | Baudax Bio, Inc. (BXRX) | 27-Jan-20 | Payment of Exercise | 1,725 | $8.51 | $14,679.80 | (2%) 92.54K to 90.82K | |
| 29-Jan-20 7:45 PM View: | Lake Ryan David Chief Financial Officer | Baudax Bio, Inc. (BXRX) | 27-Jan-20 | Option Exercise | 6,000 | -- | -- | 7% 86.54K to 92.54K | |
| 29-Jan-20 7:44 PM View: | Henwood Geraldine President and CEO Director | Baudax Bio, Inc. (BXRX) | 27-Jan-20 | Payment of Exercise | 5,051 | $8.51 | $42,984.00 | (1%) 392.94K to 387.89K | |
| 09-Dec-19 6:21 PM View: | Ashton William Director | Baudax Bio, Inc. (BXRX) | 05-Dec-19 | Grant | 20,000 | -- | -- | 257% 7.78K to 27.78K | |
| 09-Dec-19 6:22 PM View: | Churchill Winston J Director | Baudax Bio, Inc. (BXRX) | 05-Dec-19 | Grant | 20,000 | -- | -- | 257% 7.78K to 27.78K | |
| 09-Dec-19 6:17 PM View: | Altomari Alfred Director | Baudax Bio, Inc. (BXRX) | 05-Dec-19 | Grant | 20,000 | -- | -- | 239% 8.38K to 28.38K | |
| 09-Dec-19 6:23 PM View: | Weisman Wayne Director | Baudax Bio, Inc. (BXRX) | 05-Dec-19 | Grant | 20,000 | -- | -- | 189% 10.58K to 30.58K | |
| 09-Dec-19 6:18 PM View: | Henwood Geraldine President and CEO Director | Baudax Bio, Inc. (BXRX) | 05-Dec-19 | Grant | 323,958 | -- | -- | 649% 49.91K to 373.87K |
